Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Retained Earnings (2016 - 2026)

Mimedx's Retained Earnings history spans 17 years, with the latest figure at -$53.5 million for Q1 2026.

  • On a quarterly basis, Retained Earnings rose 36.44% to -$53.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$53.5 million, a 36.44% increase, with the full-year FY2025 number at -$42.7 million, up 53.23% from a year prior.
  • Retained Earnings hit -$53.5 million in Q1 2026 for Mimedx, down from -$42.7 million in the prior quarter.
  • Over the last five years, Retained Earnings for MDXG hit a ceiling of -$42.7 million in Q4 2025 and a floor of -$196.9 million in Q1 2023.
  • Historically, Retained Earnings has averaged -$128.6 million across 5 years, with a median of -$124.4 million in 2024.
  • Biggest five-year swings in Retained Earnings: fell 18.67% in 2022 and later skyrocketed 53.23% in 2025.
  • Tracing MDXG's Retained Earnings over 5 years: stood at -$191.9 million in 2022, then soared by 30.34% to -$133.7 million in 2023, then skyrocketed by 31.73% to -$91.3 million in 2024, then skyrocketed by 53.23% to -$42.7 million in 2025, then dropped by 25.44% to -$53.5 million in 2026.
  • Business Quant data shows Retained Earnings for MDXG at -$53.5 million in Q1 2026, -$42.7 million in Q4 2025, and -$57.9 million in Q3 2025.